Recently, orchestration has emerged as a central topic across life science R&D and advanced manufacturing discussions, as a direct response to structural limitations in today’s laboratory and production environments. The convergence of R&D and manufacturing, outsourcing, and the rapid expansion of data and automation are nowadays outpacing the ability of traditional, human driven coordination models to keep systems, processes, and data aligned. This was evident during industry Think Tank discussions at SmartLab Exchange Europe (1) where global pharma and biopharma leaders repeatedly highlighted the same tension: automation is widespread at the level of individual instruments and unit operations, yet organizations continue to struggle to connect these islands of automation into coherent, end to end scientific and operational workflows.
Large pharmaceutical organizations routinely operate hundreds to thousands of analytical instruments, robotics platforms, and digital systems across globally distributed laboratories and manufacturing sites. These environments generate terabytes of heterogeneous data per day, some of them under strict regulatory requirements for traceability, integrity, and reproducibility. While automation has increased local efficiency, fragmentation persists across systems, data formats, and workflow logic.
This fragmentation creates significant operational, regulatory, and strategic risk. Siloed systems and disconnected workflows drive inefficiencies, leading to costly rework, slower decision-making, and delayed projects, while the lack of end to end traceability, scientific justification, and consistent adherence to SOPs creates compliance challenges during audits and inspections. Performance becomes overly dependent on individual expertise rather than standardized, system driven processes, limiting scalability and resilience. At the same time, fragmented and poorly contextualized data reduces the impact of AI and advanced analytics, and organizations miss critical opportunities for continuous improvement across the lifecycle.
What industry leaders increasingly describe as “orchestration” is not simply integration or data movement. Rather, it is the creation of a central intelligence layer that coordinates actions, data, analytics, and decisions across the scientific and manufacturing ecosystem, linking research, development, QC, and commercial manufacturing into a single, digitally continuous landscape.
Insights from SmartLab Exchange Europe 2026 Think Tank sessions and customer engagements point to a clear shift in perspective. Early digital initiatives focused on horizontal connectivity: instrument to instrument communication or isolated system integrations. While necessary, these approaches are insufficient to deliver enterprise scale consistency, contextual decision making, or closed loop learning.